Multiplikator Forward P/S: Dexcom (DXCM)
DexCom, Inc. is expanding its glucose monitoring ecosystem by integrating sensors into smartwatches and insulin pumps. The company outsources a portion of component manufacturing and cloud data management to third-party contractors. Stable cash flow from global sales fuels R&D development. The estimated forward P/S on the GURU.Markets chart illustrates valuation trends, where the value 5.20 serves as the baseline indicator for market expectations.
Ringkesan rincian data analitis Dexcom CGM (DXCM)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal DexCom, Inc.|DXCM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal DexCom, Inc.|DXCM - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Dexcom CGM|DXCM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Dexcom|Rasio cepet dexcom.com
- rincian asil keuangan lan kelipatan valuasi:
DXCM - Penghasilan resik perusahaan|Bathi sing dikarepake DexCom, Inc.|DXCM - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Dexcom Corp|DXCM - Pangali PEG|Pangali EV/EBITDA Dexcom CGM|DXCM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Dexcom|DXCM - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan dexcom.com|DXCM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep DexCom, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:DXCM (Dexcom)
The forward P/S ratio measures the market value of DexCom, Inc. (DXCM) relative to expected revenue, reflecting the level of investor confidence in the business's growth potential. Analyzing the dynamics of this ratio allows for the separation of speculative bubbles from fundamental strengthening. By examining the forward price-to-sales ratio, one can assess the capitalization premium awarded to DexCom, Inc. (DXCM) for its status as a tech leader scaling its ecosystem through the integration of sensors into third-party insulin pumps.
Karo sapa DexCom, Inc. saingan
Rasio rega marang prakiraan pendapatan Penumbra PEN|NOVT - Multiplikator forward rega marang pendapatan|Haemonetics Corp. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Inspire Medical Systems Inc|PRCT: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator Forward P/S|InMode Ltd (INMD) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PMI|Multiplikator forward rega marang pendapatan Surmodics Inc. SRDX|Multiplikator Forward P/S SENS (Senseonics Holdings)|Multiplikator Forward P/S neuropace.com NPCE|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PFSA|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|Venus Concept Corporation - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD - Multiplikator forward rega marang pendapatan|ASXC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avinger Inc.|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Cutera Inc|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator Forward P/S NVRO|Rasio kapitalisasi marang dodolan sing dikarepake reshapelifesciences.com|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
